Denali Therapeutics DNLI
NASDAQ DNLI
$20.81 -0.17 (-0.81%)
At close: Sep 29, 2026 · 4:00 PM EDT

Denali Therapeutics (DNLI) EV to EBIT (2020 - 2021)

Updated

Denali Therapeutics' (DNLI) EV to EBIT was 201.05 for Q3 2021, up 24.5% from the prior quarter.

Analysis

Denali Therapeutics (DNLI) EV to EBIT (2020 - 2021) Analysis & Trends

Over the twelve months ended Sep 30, 2021, Denali Therapeutics' EV to EBIT came in at 36.33; for FY2020, it was 137.54.

  • Per Business Quant data, the three quarters before Q3 2021 came in at 161.49 (Q2 2021), 106.95 (Q1 2021) and 137.54 (Q4 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Denali Therapeutics 3.35 Bn 3.35 Bn 3.51 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 201.05
Jun 30, 2021 161.49
Mar 31, 2021 106.95
Dec 31, 2020 137.54
API Access

Denali Therapeutics EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=DNLI&period=max&api_key=YOUR_API_KEY